Tetanus Toxin Fragment C: Structure, Drug Discovery Research and Production - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Article Dans Une Revue Pharmaceuticals Année : 2022

Tetanus Toxin Fragment C: Structure, Drug Discovery Research and Production

Résumé

Tetanus toxoid (TTd) plays an important role in the pharmaceutical world, especially in vaccines. The toxoid is obtained after formaldehyde treatment of the tetanus toxin. In parallel, current emphasis in the drug discovery field is put on producing well-defined and safer drugs, explaining the interest in finding new alternative proteins. The tetanus toxin fragment C (TTFC) has been extensively studied both as a neuroprotective agent for central nervous system disorders owing to its neuronal properties and as a carrier protein in vaccines. Indeed, it is derived from a part of the tetanus toxin and, as such, retains its immunogenic properties without being toxic. Moreover, this fragment has been well characterized, and its entire structure is known. Here, we propose a systematic review of TTFC by providing information about its structural features, its properties and its methods of production. We also describe the large uses of TTFC in the field of drug discovery. TTFC can therefore be considered as an attractive alternative to TTd and remarkably offers a wide range of uses, including as a carrier, delivery vector, conjugate, booster, inducer, and neuroprotector
Fichier principal
Vignette du fichier
pharmaceuticals-15-00756-TTFC.pdf (1.6 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03718458 , version 1 (08-07-2022)

Identifiants

Citer

Caroline Bayart, Angélique Mularoni, Nada Hemmani, Soumeya Kerachni, Joachim Jose, et al.. Tetanus Toxin Fragment C: Structure, Drug Discovery Research and Production. Pharmaceuticals, 2022, 15 (6), pp.756. ⟨10.3390/ph15060756⟩. ⟨hal-03718458⟩
26 Consultations
70 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More